Genome Editing Market Revenue 2025 to 2034
Genome Editing Market Revenue 2025 to 2034
The global genome editing market is expected to grow from USD 10.98 billion in 2025 to USD 44.95 billion by 2034, with a CAGR of 16.95% throughout the forecast period from 2025 to 2034.
Report ID: 10108
|
Format: Databook
|
Published: August 2025
|
Delivery: Immediate
Download Sample
Customisation Request
Revenue,
USD USD 9.39 Bn
Forecast Year,
USD USD 44.95
CAGR, 2025 -
16.95%
Report Coverage
Worldwide
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
Genome Editing Market Size Analysis
Genome Editing Market Size By Application 2024 to 2034 (USD )
| Application | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Genetic Engineering | 5.16 | 6.06 | 7.12 | 8.35 | 9.80 | 11.50 | 13.50 | 15.85 | 18.60 | 21.83 | 25.62 |
| Clinical Applications | 4.23 | 4.92 | 5.73 | 6.67 | 7.76 | 9.04 | 10.52 | 12.25 | 14.26 | 16.60 | 19.33 |
Genome Editing Market Size By Technology 2024 to 2034 (USD )
| Technology | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CRISPR/Cas9 | 4.23 | 4.97 | 5.86 | 6.89 | 8.12 | 9.55 | 11.24 | 13.23 | 15.58 | 18.33 | 21.57 |
| TALENs/MegaTALs | 1.69 | 2.00 | 2.36 | 2.79 | 3.30 | 3.90 | 4.61 | 5.45 | 6.44 | 7.61 | 8.99 |
| ZFN | 1.41 | 1.63 | 1.88 | 2.16 | 2.49 | 2.88 | 3.32 | 3.82 | 4.40 | 5.07 | 5.84 |
| Meganuclease | 1.13 | 1.31 | 1.52 | 1.76 | 2.04 | 2.36 | 2.74 | 3.18 | 3.68 | 4.27 | 4.94 |
| Others | 0.94 | 1.08 | 1.23 | 1.41 | 1.62 | 1.85 | 2.11 | 2.42 | 2.76 | 3.15 | 3.60 |
Genome Editing Market Size By Delivery Method 2024 to 2034 (USD )
| Delivery Method | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Ex-vivo | 6.10 | 7.12 | 8.30 | 9.67 | 11.28 | 13.15 | 15.33 | 17.87 | 20.83 | 24.29 | 28.31 |
| In-vivo | 3.29 | 3.87 | 4.55 | 5.35 | 6.29 | 7.40 | 8.70 | 10.23 | 12.03 | 14.14 | 16.63 |
Genome Editing Market Size By End-use 2024 to 2034 (USD )
| End-use | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Biotechnology and Pharmaceutical Companies | 4.70 | 5.50 | 6.45 | 7.55 | 8.85 | 10.37 | 12.16 | 14.25 | 16.69 | 19.56 | 22.92 |
| Academic and Government Research Institutes | 3.29 | 3.83 | 4.47 | 5.21 | 6.08 | 7.09 | 8.26 | 9.64 | 11.24 | 13.10 | 15.28 |
| Contract Research Organizations | 1.41 | 1.65 | 1.93 | 2.25 | 2.63 | 3.08 | 3.60 | 4.21 | 4.93 | 5.76 | 6.74 |
Genome Editing Market Size By Region 2024 to 2034 (USD )
| Region | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 3.76 | 4.37 | 5.09 | 5.92 | 6.89 | 8.01 | 9.32 | 10.85 | 12.62 | 14.68 | 17.08 |
| Europe | 2.35 | 2.75 | 3.21 | 3.75 | 4.39 | 5.14 | 6.01 | 7.02 | 8.21 | 9.61 | 11.24 |
| Asia-Pacific | 1.88 | 2.22 | 2.62 | 3.09 | 3.65 | 4.31 | 5.09 | 6.01 | 7.10 | 8.38 | 9.89 |
| Latin America | 0.75 | 0.88 | 1.03 | 1.20 | 1.41 | 1.64 | 1.92 | 2.25 | 2.63 | 3.07 | 3.60 |
| Middle East & Africa | 0.66 | 0.77 | 0.90 | 1.05 | 1.23 | 1.44 | 1.68 | 1.97 | 2.30 | 2.69 | 3.15 |
Genome Editing Market
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
